- 积分
- 635
- 威望
- 635
- 包包
- 192
|
本帖最后由 flydayzhu 于 2010-8-28 16:37 编辑
: Z; g9 d. o# F3 j U2 K6 h8 v, o$ f; R5 J
麻烦大家了,最好是能够提供杂志版的,看着相对舒服点,谢谢~( Y8 d( T) O6 k9 t5 A
8 v& p: c# B0 q2 v+ K
1.Promotion of direct reprogramming by transformation-deficient Myc.
- M% K, A5 z1 }Nakagawa M, Takizawa N, Narita M, Ichisaka T, Yamanaka S.) G) f4 Z* z, g5 P4 c' v2 s p [( e
" }( x4 [7 Y1 Z" w
Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan. nakagawa@cira.kyoto-u.ac.jp. _$ @3 V% I, \- e! ~) S) o
http://www.ncbi.nlm.nih.gov/pubmed/20660764
$ V4 a9 B$ E6 {1 S* J( v- n; G4 o2 ]1 T9 v6 @0 _
2.Stem Cells. 2010 Aug;28(8):1349-54.! v/ P) Y/ G% k# m; ~
Aberrant epigenetic silencing of tumor suppressor genes is reversed by direct reprogramming.7 f' D: Y+ m& M, C
Ron-Bigger S, Bar-Nur O, Isaac S, Bocker M, Lyko F, Eden A.( l9 A, B9 n$ W5 [
% ~% G7 ~7 p- u1 E5 s6 GDepartments of Cell and Developmental Biology, Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.
: f& |6 v1 f% v4 H+ _2 l. b7 i& L' @7 Bhttp://www.ncbi.nlm.nih.gov/pubmed/20572015/ f; p2 b D4 h) J7 i
3 k. l( J0 X3 ?. K v9 k3.Nat Biotechnol. 2010 May;28(5):521-6. Epub 2010 May 2.
0 t+ x8 h$ O: B& |! zDynamic single-cell imaging of direct reprogramming reveals an early specifying event.
' A: G6 o& A) |/ YSmith ZD, Nachman I, Regev A, Meissner A.
% n; c; p" n, `; U2 R* e$ v
1 ?- M9 T8 o3 c$ ?8 Y" v. a! t& m; d# C& dBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.9 ]- \5 P/ @* A7 x
Comment in:
+ m" y/ P6 ~) {; y/ h" ?# W6 n, y
Regen Med. 2010 Jul;5(4):501-3.6 v: I9 U3 r( Y' {6 [
http://www.ncbi.nlm.nih.gov/pubmed/20436460
6 \* V9 b- a; r. F% ~
0 T9 L2 v: \4 P4.PLoS One. 2010 Mar 24;5(3):e9838.0 O+ p D0 {9 j$ `' N2 V& `: `
Direct reprogramming of rat neural precursor cells and fibroblasts into pluripotent stem cells.0 a) A8 s+ t# |8 R
Chang MY, Kim D, Kim CH, Kang HC, Yang E, Moon JI, Ko S, Park J, Park KS, Lee KA, Hwang DY, Chung Y, Lanza R, Kim KS.
3 a; k& U6 y& c, a# s4 A+ ^
( m) g$ J8 \& X$ N8 hMolecular Neurobiology Laboratory, McLean Hospital, Harvard Medical School, Belmont, Massachusetts, United States of America.
; y( c% Z E2 `2 v: p: qhttp://www.ncbi.nlm.nih.gov/pubmed/20352099
: Q) S% ~% G4 A, ?) e# w# T, F; _2 j; K; F: M% j
5.Dev Growth Differ. 2010 Apr;52(3):319-33. Epub 2010 Mar 7.8 Z3 W4 [& |. i) n3 v
Direct reprogramming 101.* S+ i0 r$ ]/ s& A, h6 J& Y* p7 O
Takahashi K.% }4 B- H' H5 B! e6 D# z. E7 H# }2 ~
6 t$ U' W' k. {Center for iPS cell Research and Application, Institute for Integrated Cell-Material Sciences, Kyoto University, Sakyo-ku, Kyoto, Japan. takahash@cira.kyoto-u.ac.jp
% Q. M$ ~# s8 W5 v' ahttp://www.ncbi.nlm.nih.gov/pubmed/20298260
+ L3 t+ K; W7 r* a
$ | Y$ G- F$ f1 ]3 K6.Nature. 2009 Oct 1;461(7264):649-3.2 @% ?" P: V% J+ {
Direct reprogramming of human neural stem cells by OCT4.6 G% _' }& ]& [- T) Q
Kim JB, Greber B, Araúzo-Bravo MJ, Meyer J, Park KI, Zaehres H, Schöler HR.
: }6 l6 V! Z3 b* `4 ?1 N. [" T; e/ x5 }# V/ R; M3 K V1 b
Max Planck Institute for Molecular Biomedicine, Department of Cell and Developmental Biology, Röntgenstrasse 20, 48149 Münster, NRW, Germany.! i: U6 }, i9 S5 P" ?
http://www.ncbi.nlm.nih.gov/pubmed/19718018
# l3 f, Y- S# O
0 `& v7 Q& K6 P6 S# E: v7.Blood. 2009 Aug 27;114(9):1764-7. Epub 2009 Jun 29.
D" H' t3 R. M' T/ w" ~Definitive proof for direct reprogramming of hematopoietic cells to pluripotency.6 Q# C# |2 h; S! D+ Y
Okabe M, Otsu M, Ahn DH, Kobayashi T, Morita Y, Wakiyama Y, Onodera M, Eto K, Ema H, Nakauchi H.' j1 {3 ~( d" x& K! S5 W3 d
" b, K. p. Q- ~. E0 o- G, YDivision of Stem Cell Therapy, Center for Stem Cell and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan.( o* |: o4 Y6 F3 v" a
http://www.ncbi.nlm.nih.gov/pubmed/19564635
T! ], F' V3 K2 X2 }5 q+ }* c) F: y5 c6 T
3 W7 r2 G; G% Q% b8.Cell Biol Int. 2009 Dec;33(12):1268-73. Epub 2009 Jun 12.
! |& Y7 x' t" T0 C3 P- DRole of MEF feeder cells in direct reprogramming of mousetail-tip fibroblasts.
6 _8 c( X! v: w6 O3 n: l/ `Chen M, Sun X, Jiang R, Shen W, Zhong X, Liu B, Qi Y, Huang B, Xiang AP, Ge J.
9 T$ Y& C* G9 t: `) f* g8 E. Z' Q2 m' O0 w' g ~" H2 v6 Q6 Y
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China.
1 B9 u, r) u1 @8 jhttp://www.ncbi.nlm.nih.gov/pubmed/19524692 c* Z& A4 I+ L2 p2 ?% } k c
5 c0 ~' w* ]: g9.Mol Ther. 2009 Jun;17(6):947-53. Epub 2009 Mar 31.
6 z: m: D1 l! k- ?% zUpping the ante: recent advances in direct reprogramming.
2 T& d5 @7 D" q' l! pMüller LU, Daley GQ, Williams DA.
7 x5 n3 F& f7 K0 k7 @( B8 I0 ]7 S3 U; g
Department of Medicine, Division of Pediatric Hematology Oncology, Children's Hospital Boston, Boston, Massachusetts 02115, USA.
. Z- X9 k4 Q- }Comment in:
, t) y9 h' h' w+ I. K8 `7 U9 J w& I* J. c
Mol Ther. 2009 Jun;17(6):929-30.
& I! p i1 ]% ^http://www.ncbi.nlm.nih.gov/pubmed/19337233
& ~' K( ~, z7 n% o
4 U4 j6 y' Q8 n! l8 w. {10.Cell Stem Cell. 2008 Sep 11;3(3):346-53.
( k# G2 r2 K1 cA drug-inducible system for direct reprogramming of human somatic cells to pluripotency.. d2 _1 z7 b5 m) k" n
Hockemeyer D, Soldner F, Cook EG, Gao Q, Mitalipova M, Jaenisch R.
2 U/ u$ L( {, H) S) k: g2 s1 q0 t9 I$ l' A
The Whitehead Institute, 9 Cambridge Center, Cambridge, MA 02142, USA.
' V- A1 Z- v) z# Q+ j9 B# q* d1 X% Hhttp://www.ncbi.nlm.nih.gov/pubmed/18786421/ b! H6 `' r. K* E. U: `- Y
2 V& q3 R* k9 n- C! S
11.Nat Biotechnol. 2008 Aug;26(8):916-24. Epub 2008 Jul 1.
; B4 \: O4 H% Y+ xA drug-inducible transgenic system for direct reprogramming of multiple somatic cell types.8 i% W8 X# q- o- m; y! u
Wernig M, Lengner CJ, Hanna J, Lodato MA, Steine E, Foreman R, Staerk J, Markoulaki S, Jaenisch R.* j- C! U- R- j/ @2 p- z
% N9 E0 {9 R& }! n" i# }
Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts 02142, USA.
% C& `' H: `* R6 @) z8 n6 m6 jhttp://www.ncbi.nlm.nih.gov/pubmed/18594521# _8 S: h0 s* F; x$ g( s
9 r M; l' [5 A, i. a$ Q
12.Nature. 2008 Jul 3;454(7200):49-55. Epub 2008 May 28.
: u l: D$ N" K5 \( |9 a) kDissecting direct reprogramming through integrative genomic analysis.
0 {7 v; r& l$ _3 @Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P, Bernstein BE, Jaenisch R, Lander ES, Meissner A.
! e6 R4 M0 h5 {2 F. w5 D% I3 w6 O
1 V' I4 N4 F/ N+ g: nBroad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA.( g( W6 a9 f: g$ |( E( E+ ^
http://www.ncbi.nlm.nih.gov/pubmed/18509334
6 C1 f% E% A! v& ?7 m" P4 U4 R- e" }4 m
13.Cell. 2008 Apr 18;133(2):250-64.
8 n1 M; `* Y2 S3 }+ t/ {Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency.
. R1 x9 l2 y+ A4 G6 zHanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, Wernig M, Creyghton MP, Steine EJ, Cassady JP, Foreman R, Lengner CJ, Dausman JA, Jaenisch R.: K0 k6 I% w$ k) }2 ^
" \3 }* m" T0 a" q" n# `2 X
The Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
! C/ h8 H4 {1 b) F; vhttp://www.ncbi.nlm.nih.gov/pubmed/18423197
9 n @9 g" R3 r/ h+ u
9 u% n. w. d* c+ ^2 B1 T14.Cell Stem Cell. 2008 Feb 7;2(2):151-9.
, m( P1 u2 w1 R* I' R: j/ NSequential expression of pluripotency markers during direct reprogramming of mouse somatic cells.: s& f) o* {; Q5 X# v$ F7 m
Brambrink T, Foreman R, Welstead GG, Lengner CJ, Wernig M, Suh H, Jaenisch R.
, u0 p9 f% u3 j# K2 z. V) A
h* d5 i- E7 ~& x' N: \# W* kWhitehead Institute for Biomedical Research, Massachusetts Institute of Technology, 9 Cambridge Center, Cambridge, MA 02142, USA.
) i5 y! C: c/ p1 K* V) f! \http://www.ncbi.nlm.nih.gov/pubmed/18371436 `; Y& G; S/ s) z3 O @2 e
$ w0 e5 h8 U. y) S9 r/ F: [9 N3 w5 C15.Cell Stem Cell. 2008 Jan 10;2(1):10-2. Epub 2007 Dec 13.
# S; k) Z2 i3 O4 qc-Myc is dispensable for direct reprogramming of mouse fibroblasts.
: m6 }7 N: ]; r$ sWernig M, Meissner A, Cassady JP, Jaenisch R.
7 A0 k: m) X7 U% J% Ohttp://www.ncbi.nlm.nih.gov/pubmed/18371415
. @% N! t4 u5 h* `" v" _/ w4 Z' u' W" z2 b
16.Cell Stem Cell. 2007 Dec 13;1(6):593-4.
3 a# u( m1 M/ H$ c$ b5 mThe first direct reprogramming of adult human fibroblasts. x/ V+ F$ X: ?- y- c5 e& K( g
Wilmut I.
1 z; s, x# G4 C0 ]
/ B# i/ V! M. M. X, T9 UScottish Centre for Regenerative Medicine, University of Edinburgh, Edinburgh EH16 4SB, UK. ian.wilmut@ed.ac.uk
5 Q; k' V; S1 hhttp://www.ncbi.nlm.nih.gov/pubmed/18371396
, k R M! T- c1 A/ {& R0 u' F+ A
q ]! u5 Z( ?- y5 ?1 j0 S+ p7 p; i17.Nat Biotechnol. 2007 Oct;25(10):1177-81. Epub 2007 Aug 27.
h# {, k% W/ H/ ]; [Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells.! Q6 _* ^3 N1 a; i/ g% O* P
Meissner A, Wernig M, Jaenisch R.
2 L9 p- |3 F" y3 m5 p, \* ~3 B6 _1 g! X) }1 ^
Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Nine Cambridge Center, Cambridge Massachusetts 02142, USA.. a3 @- T1 q& s- C! V% L- j$ C
http://www.ncbi.nlm.nih.gov/pubmed/17724450 |
|